Daniel Abdun-Nabi, President & CEO at Emergent BioSolutions Inc. (EBS), sold 15,000 shares at $39.92 ($599K) on 2017-09-27, disclosed to the SEC on 2017-09-29.
Open-market sale of $599k EBS by President & CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| EBS | SELL | 2018-09-06 | $5.5M | — | Filing → |
| EBS | SELL | 2018-06-07 | $823K | — | Filing → |
| EBS | SELL | 2018-01-04 | $1.0M | — | Filing → |